株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の放射性医薬品市場:2017~2021年

Global Radiopharmaceuticals Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 541272
出版日 ページ情報 英文 83 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
世界の放射性医薬品市場:2017~2021年 Global Radiopharmaceuticals Market 2017-2021
出版日: 2017年08月09日 ページ情報: 英文 83 Pages
概要

世界の放射性医薬品市場は、2017~2021年にかけCAGR9.02%で拡大すると予測されています。放射性医薬品は本来の特性により医療分野で幅広く応用されています。癌市場からの需要拡大により、同市場は今後拡大するものとみられています。

当レポートでは、世界の放射性医薬品市場について調査し、市況と用途別、地域別動向、市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 パイプライン分析

第7章 用途別市場セグメンテーション

  • 診断
  • 治療

第8章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 意思決定の枠組み

第10章 促進因子と課題

第11章 市場動向

  • 放射性医薬品開発のための提携
  • サイクロトロンに基づく生産

第12章 ベンダー環境

第13章 主要ベンダー分析

  • Bayer
  • Cardinal Health
  • GE Healthcare
  • Lantheus Medical Imaging
  • その他の注目すべきベンダー

第14章 付録

図表
  • Exhibit 01: Characteristics of radiopharmaceuticals
  • Exhibit 02: Factors affecting the development of new radiopharmaceutical
  • Exhibit 03: Applications of radiopharmaceuticals
  • Exhibit 04: Advantages and disadvantages of radiopharmaceuticals
  • Exhibit 05: Global radiopharmaceuticals market snapshot
  • Exhibit 06: Global radiopharmaceuticals market 2016-2021 ($ millions)
  • Exhibit 07: Opportunity analysis in global radiopharmaceuticals market
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Key pipeline molecules by vendors
  • Exhibit 10: Key clinical trials
  • Exhibit 11: Segmentation of global radiopharmaceuticals market by application 2016
  • Exhibit 12: Segmentation of global radiopharmaceuticals market by application 2016 and 2021 (%)
  • Exhibit 13: Global radiopharmaceutical diagnostics market 2016-2021 ($ millions)
  • Exhibit 14: Diagnostic radiopharmaceuticals used in various clinical practices
  • Exhibit 15: Techniques of radiopharmaceutical imaging
  • Exhibit 16: Global radiopharmaceutical therapeutics market 2016-2021 ($ millions)
  • Exhibit 17: Commonly used radiopharmaceuticals for targeted radionuclide therapy
  • Exhibit 18: Treatment of tumors and cancers with radioisotopes
  • Exhibit 19: Segmentation of global radiopharmaceuticals market based on geography 2016 and 2021 (%)
  • Exhibit 20: Segmentation of global radiopharmaceuticals market revenue by geography 2016-2021 ($ millions)
  • Exhibit 21: Segmentation of global radiopharmaceuticals market share by geography 2016-2021 (%)
  • Exhibit 22: Market scenario in Americas
  • Exhibit 23: Radiopharmaceuticals market in Americas 2016-2021 ($ millions)
  • Exhibit 24: Radiopharmaceuticals market scenario in EMEA
  • Exhibit 25: Radiopharmaceuticals market in EMEA 2016-2021 ($ millions)
  • Exhibit 26: Radiopharmaceuticals market scenario in APAC
  • Exhibit 27: Radiopharmaceuticals market in APAC 2016-2021 ($ millions)
  • Exhibit 28: Functions of JRIA
  • Exhibit 29: Facts about the neurological disorders
  • Exhibit 30: Problems associated with the radiopharmaceutical drugs
  • Exhibit 31: Competitive structure analysis of the global pharmaceutical market 2016
  • Exhibit 32: Bayer: Key highlights
  • Exhibit 33: Bayer: Strength assessment
  • Exhibit 34: Bayer: Strategy assessment
  • Exhibit 35: Bayer: opportunity assessment
  • Exhibit 36: Cardinal Health: Key highlights
  • Exhibit 37: Cardinal Health: Strength assessment
  • Exhibit 38: Cardinal Health: Strategy assessment
  • Exhibit 39: Cardinal Health: Opportunity assessment
  • Exhibit 40: GE Healthcare: Key highlights
  • Exhibit 41: GE Healthcare: Strength assessment
  • Exhibit 42: GE Healthcare: Strategy assessment
  • Exhibit 43: GE Healthcare: Opportunity assessment
  • Exhibit 44: Lantheus Medical Imaging: Key highlights
  • Exhibit 45: Lantheus Medical Imaging: Strength assessment
  • Exhibit 46: Lantheus Medical Imaging: Strategy assessment
  • Exhibit 47: Lantheus Medical Imaging: Opportunity assessment
目次
Product Code: IRTNTR14246

About Radiopharmaceuticals

Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.

Technavio's analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer,
  • Cardinal Health,
  • GE Healthcare,
  • Lantheus Medical Imaging

Other Prominent Vendors

  • ABT Molecular Imaging
  • Advanced Accelerator Applications
  • Algeta
  • Eczacibasi-Monrol Nuclear Products
  • FUJIFILM Holdings
  • Isologic Innovative Radiopharmaceuticals
  • Nordion
  • Piramal Imaging
  • RadioMedix
  • Triad Isotopes

Market driver

  • Rising burden of the neurological disorders
  • For a full, detailed list, view our report

Market challenge

  • Shortage of radioisotopes
  • For a full, detailed list, view our report

Market trend

  • Partnerships for development of radiopharmaceuticals
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Pipeline analysis

PART 07: Market segmentation by application

  • Diagnostics
  • Therapeutics

PART 08: Geographical segmentation

  • Radiopharmaceuticals market in Americas
  • Radiopharmaceutical market in EMEA
  • Radiopharmaceuticals market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Partnerships for development of radiopharmaceuticals
  • Production based on cyclotron

PART 12: Vendor landscape

PART 13: Key vendor analysis

  • Bayer
  • Cardinal Health
  • GE Healthcare
  • Lantheus Medical Imaging
  • Other prominent members

PART 14: Appendix

  • List of abbreviations
Back to Top